Abstracts
Showing 798 abstracts.
A Phase I/II, Multicenter, Open-Label, Noncomparative Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth
Conference
49th Intersci Conf on Antimicrobial Agents & Chemotherapy
Study
P1066
Authors
Sharon Appelbaum Nachman, Pearl Samson, Lisa M. Frenkel, Edward P. Acosta, Hedy Teppler, Terence Fenton, Edward Handelsman, Carol J. Worrell, Bobbie L. Graham, Andrew A. Wiznia24 Week Safety and efficacy from IMPAACT P1066: A Phase I/II, Multicenter, Open-Label, Noncomparative Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth
Conference
49th Intersci Conf on Antimicrobial Agents & Chemotherapy
Study
P1066
Authors
Sharon Appelbaum Nachman, Pearl Samson, Lisa M. Frenkel, Edward P. Acosta, Hedy Teppler, Terence Fenton, Edward Handelsman, Carol J. Worrell, Bobbie L. Graham, Andrew A. WizniaNevirapine vs Kaletra for treatment of single dose Nevirapine-exposed HIV-infected infants: preliminary results from IMPAACT P1060.
Conference
5th IAS Conf on HIV Pathogenesis, TX & Prevention
Study
P1060
High prevalence of drug resistance amongst HIV-exposed and infected children with culture confirmed tuberculosis enrolled on a tuberculosis prevention trial.
Conference
5th IAS Conf on HIV Pathogenesis, TX & Prevention
Study
P1041
Authors
Anneke C. Hesseling, Soyeon Kim, Shabir A. Madhi, Sharon Appelbaum Nachman, Hendrik Simon Schaaf, Thomas C. Victor, Charles Debeaux Mitchell, Avy Violari, George D. McSherry, Mark F. CottonNevirapine (NVP) vs lopinavir-ritonavir (LPV/r)-based antiretroviral therapy (ART) in single dose nevirapine (sdNVP)-exposed HIV-infected infants: preliminary results from the IMPAACT P1060 trial
Conference
5th IAS Conf on HIV Pathogenesis, TX & Prevention
Study
P1060
Authors
Paul Palumbo, Avy ViolariA novel chewable pediatric fixed-dose combination (FDC) of zidovudine (ZDV), lamivudine (3TC), nevirapine (NVP): pharmacokinetics and safety in HIV-infected Thai children
Conference
International Workshop on HIV Pediatrics
Study
P1069
Authors
Wasana Prasitsuebsai, Tim Roy Cressey, Nirun Vanprapar, Edmund Capparelli, Linda Aurpibul, Virat Sirisanthana, Petronella Muresan, Chanin Limwongse, Achara Eksaengsri, Elizabeth (Betsy) Smith, Kenneth McIntosh, Ram Yogev, Kulkanya ChokephaibulkitPharmacokinetics and Safety of Dispersible and Immediate Release FDC Abacavir/ Dolutegravir/ Lamivudine in Children with HIV Weighing =14 kg: Preliminary Results from IMPAACT 2019
Conference
International Workshop on HIV Pediatrics
Study
IMPAACT 2019
Authors
Kristina Brooks, Jennifer Kiser, Pearl Samson, Yasha Rani, Shawn Ward, Timothy Cressey, Haseena Cassim, Jaime Deville, Gaerolwe Masheto, Ponego Ponatshego, Anne Coletti, Kathryn Lypen, Iris Mustich, Barbara Heckman, Mark Lojacono, Rachel Bowman, Dwight Yin, Ellen Townley, Sai Majji, Edward Acosta, Annie Buchanan, Cindy Brothers, Hardik Chandasana, Helena Rabie, Patricia Flynn, IMPAACT 2019 TeamBone mineral density/content of postpartum mothers taking treatment including DTG vs EFV, TDF vs TAF in pregnancy and their infants: randomized IMPAACT 2010 trial
Conference
International Workshop on HIV Pediatrics
Study
IMPAACT 2010
Authors
Tapiwa Mbengeranwa, Lauren Ziemba, Benjamin Johnston, Haseena Cassim, Gerhard Theron, Z. Ngqawana, Deo Wabwire, Katie McCarthy, Nahida Chakhtoura, Patrick Jean-Philippe, John Shepherd, Shahin Lockman, Lameck Chinula, Lynda Stranix-Chibanda, IMPAACT 2010/VESTED Study Team and investigatorsThe Effect of HIV and Latent Tuberculosis Infection During Pregnancy on Infant Immune Development
Conference
International Workshop on HIV Pediatrics
Study
P1078
Authors
Kimberly Shankwitz, Lesley de Armas, Alexander Kizhner, Suresh Pallikkuth, Rajendra Pahwa, Grace Montepiedra, Mauricio Pinilla, Amita Gupta, Savita PahwaAbacavir Weight-Band Dosing for Infants in the first 4 weeks of life
Conference
International Workshop on HIV Pediatrics
Study
P1106